Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study of Deferasirox Relative to Subcutaneous Deferoxamine in Sickle Cell Disease Patients

ClinicalTrials.gov ID: NCT00110617

Public ClinicalTrials.gov record NCT00110617. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 4:51 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Open-label, Multi-center, Phase II Study to Evaluate the Safety and Efficacy of Deferasirox (ICL670) 20 mg/kg/Day Relative to Subcutaneous Deferoxamine in Sickle Cell Disease Patients With Iron Overload From Repeated Blood Transfusions

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will examine the long-term safety and efficacy of Deferasirox in patients with sickle cell disease and iron overload from repeated blood transfusions.

Study identification

NCT ID
NCT00110617
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
212 participants

Conditions and interventions

Eligibility (public fields only)

Age range
2 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2005 (Type not available)
Primary completion
Apr 2008 (Actual)
Completion
Apr 2008 (Actual)
Last update posted
May 26, 2011

2005 – 2008

United States locations

U.S. sites
56
U.S. states
20
U.S. cities
35
Facility City State ZIP Site status
University of Alabama Pediatric Hematology/Oncology Birmingham Alabama 35233 —
University of Alabama Medical center Birmingham Alabama 35294 —
University of South Alabama Medical Center Mobile Alabama 36604 —
University of South Alabama Mobile Alabama 36617 —
Loma Linda University Medical Center Loma Linda California 92354 —
Children's Hospital Oakland Oakland California 94609 —
Center for Cancer and Blood Disorders Washington D.C. District of Columbia 20010-2970 —
Children's National Medical Center Washington D.C. District of Columbia 20010 —
Howard University Hospital Washington D.C. District of Columbia 20059 —
Miami Children's Hospital Miami Florida 33155 —
Tampa Children's Hospital at St Joseph's Tampa Florida 33607-6387 —
Tampa Children's Hospital at St. Joseph's Tampa Florida 33607-6387 —
H. Lee Muffit Cancer Center and Research Institute/James A. Haley Veterans Hospital Tampa Florida 33612 —
Emory University School of Medicine Atlanta Georgia 30303 —
Children's Healthcare of Atlanta at Scottish Rite Atlanta Georgia 30342 —
Adult Sickle Cell Clinic Augusta Georgia 30912-3128 —
Backus Children's Hospital Savannah Georgia 31403 —
University of Illinois at Chicago Chicago Illinois 60612 —
Children's Memorial Hospital Chicago Illinois 60614-3394 —
Pediatric Sickle Cell Program/James Whitcomb Riley Hospital for Children Indianapolis Indiana 46202 —
St. Jude Children's Hospital Affiliate Baton Rouge Louisiana 70808 —
Tulane University Sickle Cell Center New Orleans Louisiana 70112 —
Children's Hospital New Orleans Louisiana 70118 —
LSU Health Sciences Center/Carroll W. Feist Professor of Cancer Research Shreveport Louisiana 71130 —
Brigham and Woman's Hospital/Harvard Medical School Boston Massachusetts 02115 —
Children's Hospital Boston Boston Massachusetts 02115 —
Children's Hospital Boston Massachusetts 02115 —
University of Michigan Ann Arbor Michigan 48109-0238 —
Karmanos Cancer Institute Detroit Michigan 48201 —
Washington University School of Medicine St Louis Missouri 63110 —
SUNY Downstate Medical Center Brooklyn New York 11203 —
New York Methodist Hospital Brooklyn New York 11215 —
Weill Medical College of Cornell University New York New York 10021 —
Columbia University New York New York 10032 —
Sickle Cell Center, Montefiore Hospital The Bronx New York 10467-2490 —
Carolinas Medical Transplant Center Charlotte North Carolina 28232 —
University of Cincinnati Cincinnati Ohio 45219 —
Children's Hospital Medical Center Cincinnati Ohio 72764 —
The University of Oklahoma Oklahoma City Oklahoma 73104 —
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104-4399 —
Pennsylvania Oncology/Hematology Philadelphia Pennsylvania 19106 —
Jefferson University Philadelphia Pennsylvania 19107 —
Drexel University College of Medicine Philadelphia Pennsylvania 19134-1095 —
Children's Hospital of Pittsburgh Pittsburgh Pennsylvania 15213 —
Hillman Cancer Center Pittsburgh Pennsylvania 15232 —
Liberty Hematology Oncology Center Columbia South Carolina 29203 —
Palmetto Health Clinical Trials Columbia South Carolina 29203 —
Santee Hematology/Oncology Sumter South Carolina 29150 —
St Jude's Children's Research Hospital Memphis Tennessee 38105-2794 —
St. Jude's Children Research Hospital Memphis Tennessee 38105 —
Cooks Children's Hospital Fort Worth Texas 76104-2724 —
Texas Children's Hospital/Baylor College of Medicine Houston Texas 77030-2399 —
Scott and White Memorial Hospital & Clinics Temple Texas 76508 —
Children's Hospital of the King's Daughter Norfolk Virginia 23507 —
Medical College of Virginia Richmond Virginia 23298-0306 —
Virginia Commonwealth University Richmond Virginia 23298-0646 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00110617, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 26, 2011 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00110617 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →